[Early immunomodulatory treatment of multiple sclerosis. Economic aspects].
Czapliński
A
A
D000276:Adjuvants, Immunologic / Q000191:economics* / Q000627:therapeutic use*; D017048:Health Care Costs; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000191:economics*; D013997:Time Factors
D000276:Adjuvants, Immunologic